Poster Presentation ESA-SRB-APEG-NZSE 2022

Children and adolescents with Type 1 Diabetes in New Zealand: an online survey of workforce and outcomes (#445)

Calum Fisher 1 , Martin de Bock 1
  1. University of Otago, Christchurch, CANTERBURY, New Zealand

Background: Type 1 diabetes (T1D) is one of the most common chronic diseases in children and adolescents in New Zealand and the incidence of the disease continues to rise, both in New Zealand1 and worldwide2.  Unfortunately, glycaemic control in New Zealand patients with T1D has generally been poorer than other international cohorts, and there is considerable inequity faced by Māori and the socially deprived3. Optimal management requires multidisciplinary input from many health-care professionals (HCP)4. However, a previous HCP survey of tertiary centres in Australasia demonstrated that the T1D workforce for 2016 was under-resourced and failed to meet the resource allocation proposed5. Five years on, it is important to assess the current paediatric T1D HCP workforce and outcomes in New Zealand.

Aim: To survey the model of care and workforce that manage children with T1D in New Zealand and link to outcomes previously gathered and provide further scope regarding the upcoming reform of district health boards.

Method: A representative for each tertiary diabetes services in New Zealand operating for the 2021 calendar year was asked to participate in an online survey. Respondents were asked the amount of FTE their district health board (DHB) provided for caring for children and adolescents with T1D. Results were compared to previously reported data on regional glycaemic outcomes.

Results: Data collection is still ongoing and will be complete by the November scientific meeting.

Conclusions: Tertiary and regional centres in New Zealand have previously been under-resourced. This study will determine whether the resource allocation for the T1D workforce is appropriate and relate these findings to regional glycaemic outcomes.

  1. 1. Derraik JGB, Reed PW, Jefferies C, Cutfield SW, Hofman PL, Cutfield WS. Increasing Incidence and Age at Diagnosis among Children with Type 1 Diabetes Mellitus over a 20-Year Period in Auckland (New Zealand). PLOS ONE. 2012;7(2):e32640. doi:10.1371/journal.pone.0032640
  2. 2. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. N Engl J Med. Apr 13 2017;376(15):1419-1429. doi:10.1056/NEJMoa1610187
  3. 3. Chepulis L, Tamatea JAU, Wang C, Goldsmith J, Mayo CTH, Paul RG. Glycaemic control across the lifespan in a cohort of New Zealand patients with type 1 diabetes mellitus. https://doi.org/10.1111/imj.14816. Internal Medicine Journal. 2021/05/01 2021;51(5):725-731. doi:https://doi.org/10.1111/imj.14816
  4. 4. Pihoker C, Forsander G, Fantahun B, et al. ISPAD Clinical Practice Consensus Guidelines 2018: The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatric Diabetes. 2018;19(S27):84-104. doi:https://doi.org/10.1111/pedi.12757
  5. 5. de Bock M, Jones TW, Fairchild J, Mouat F, Jefferies C. Children and adolescents with type 1 diabetes in Australasia: An online survey of model of care, workforce and outcomes. Journal of Paediatrics and Child Health. 2019;55(1):82-86. doi:https://doi.org/10.1111/jpc.14122